CHM
Click for more information
0.00% 1.9¢ chimeric therapeutics limited

Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial, page-13

  1. cklamov
    260 Posts.
    lightbulb Created with Sketch. 49
    clock Created with Sketch.
    02/11/23
    14:10
    Post #: 70690590
    So the 1B trial commenced sooner than 2024 interesting
    CHM Price at posting: 3.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

IMM Immutep targets $100m for lung cancer drug trial tests
right-arrow Created with Sketch.
HZR Hazer Group and POSCO team up to look at low carbon steel
right-arrow Created with Sketch.
LGP Little Green Pharma's cannabis sales leap 30%
right-arrow Created with Sketch.
SPA Spacetalk makes European Market Reentry with Elisa
right-arrow Created with Sketch.
LU7 Lithium Universe inks final layout for Becancour lithium plant as DFS rolls on
right-arrow Created with Sketch.
NEWS The Big Deal: Welcoming Warren Tredrea's words on the business of sport
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $16.39M
Open High Low Value Volume
1.8¢ 1.9¢ 1.7¢ $66.72K 3.721M

Buyers (Bids)

No. Vol. Price($)
6 500356 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 471412 5
View Market Depth
Last trade - 16.10pm 04/06/2024 (20 minute delay) ?
Last
1.8¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
1.7¢ 1.8¢ 1.7¢ 579076
Last updated 15.44pm 04/06/2024 ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.